Multicenter, open-label study using imiquimod 5% cream in 1 or 2 4-week courses of treatment for multiple actinic keratoses on the head

被引：0
|
作者：
Stockfleth, E
Schmook, T
Carey-Yard, M
Bichel, J
机构：
[1] Charite, Dept Dermatol, Berlin, Germany
[2] 3M Medica, Neuss, Germany
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2006年 / 54卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB71 / AB71
页数：1
相关论文
共 50 条
  • [1] Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head
    Stockfleth, E.
    Sterry, W.
    Carey-Yard, M.
    Bichel, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 : 41 - 46
  • [2] Treatment of multiple, multiform actinic keratoses on the head with imiquimod 5% cream
    Stockfleth, Eggert
    Ulrich, Claas
    Lange-Asschenfeldt, Bernhard
    Kremer, Hans-Joachim
    Drecoll, Ulrike
    Maus, Joachim
    Roewert-Huber, Joachim
    EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (04) : 355 - 359
  • [3] Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the head
    Rivers, Jason K.
    Rosoph, Les
    Provost, Nathalie
    Bissonnette, Robert
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2008, 12 (03) : 97 - 101
  • [4] Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial
    Salasche, SJ
    Levine, N
    Morrison, L
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (04) : 571 - 577
  • [5] Topical treatment of actinic keratoses with potassium dobesilate 5% cream. A preliminary open-label study
    P Cuevas
    W Espinoza
    C Pérez
    J Angulo
    C Giménez-Gallego
    European Journal of Medical Research, 16
  • [6] TOPICAL TREATMENT OF ACTINIC KERATOSES WITH POTASSIUM DOBESILATE 5% CREAM. A PRELIMINARY OPEN-LABEL STUDY
    Cuevas, P.
    Espinoza, W.
    Perez, C.
    Angulo, J.
    Gimenez-Gallego, G.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 (02) : 67 - 70
  • [7] Combination therapy with imiquimod and 5-fluorouracil cream for the treatment of actinic keratoses, a prospective open-label nonrandomized uncontrolled pilot trial
    Regester, Richard Maxwell
    Cannella, Amy C.
    Hirz, Julianna
    Sayles, Brian
    Schlange, Stacie
    Rau, Amy
    Sayles, Harlan R.
    Griess, Anthony J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (06) : 1247 - 1249
  • [8] An open-label 18-month study of fluorouracil cream 0.5% for the treatment of actinic keratoses
    Stough, Dow
    Davis, Steven A.
    Bucko, Alicia
    Rafal, Elyse
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB102 - AB102
  • [9] Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study
    Stough, Dow
    Bucko, Alicia D.
    Vamvakias, George
    Rafal, Elyse S.
    Davis, Steven A.
    CUTIS, 2010, 85 (05): : 267 - 273
  • [10] Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head
    Jorizzo, Joseph
    Dinehart, Scott
    Matheson, Robert
    Moore, Jeffrey K.
    Ling, Mark
    Fox, Terry L.
    McRae, Scott
    Fielder, Sandra
    Lee, James H.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (02) : 265 - 268
12345